Endogenous retroviruses and response to immune checkpoint inhibitors: mechanisms, clinical evidence, and therapeutic implications - Poll - MDSpire

Endogenous retroviruses and response to immune checkpoint inhibitors: mechanisms, clinical evidence, and therapeutic implications

  • By

  • Fanyuan Wu

  • Quezhu Danzeng

  • Runxi Wu

  • Yi Shen

  • Guang Shi

  • May 20, 2026

  • 0 min

Share

Original Source(s)

Endogenous retroviruses and response to immune checkpoint inhibitors: mechanisms, clinical evidence, and therapeutic implications

  • by Fanyuan Wu, Quezhu Danzeng, Runxi Wu, Yi Shen, Guang Shi

  • May 20, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Management of toxicities from antibody – drug conjugates in breast cancer